journal article·2010-12Open access

Antimicrobial Properties and Release Profile of Ampicillin from Electrospun Poly(εepsilon;-caprolactone) Nanofiber Yarns

Hang Liu, Karen K. Leonas, Yiping Zhao

Abstract

Poly(εepsilon;-caprolactone) (PCL) electrospun fibers containing ampicillin sodium salt have been produced and twisted into nanofiber yarns. The fiber diameters and crystallinity, the in vitro antimicrobial properties of the yarns, and the in vitro release of ampicillin from yarns containing various ampicillin concentrations are studied. Decreased fiber diameters and reduced diameter variation are observed with the addition of ampicillin salt into the polymer solution. The results from the zone of inhibition test of the yarns against both gram-positive Staphylococcus aureus and gram-negative Klebsiella pneumoniae indicate that the released ampicillin retains its effectiveness after the production processes, therefore the as-spun yarns are antimicrobial active. A burst release of ampicillin from the yarns has been observed in the first hour, and the release is almost completed in 96 hours. The burst release is believed to be due to the low compatibility of ampicillin with PCL, the accumulation of ampicillin on fiber surface and the small fiber diameters. An empirical release model is developed to describe the release profile. The results indicate that the electrospun nanofibers yarns will have a great potential to be used for biomaterials, such as surgical sutures, to decrease the surgical site infection rate.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Electrospun Nanofibers in Biomedical Applications · Tissue Engineering and Regenerative Medicine · Silk-based biomaterials and applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Apparel, Merchandising, Design and Textiles, Washington State University, Pullman, WA 99164, USA

Department of Physics and Astronomy, University of Georgia, Athens, GA 30602, USA

References (48)

Show source-provided references
1. Inserting and replacing GORE DUALMESH PLUS biomaterial inhibits implant infections by drug-resistant ‘Superbugs” and resists biofilm development, Vol. 2008, Business Wire, 2007.
2. Bide M. · AATCC Review · 2005 · 7 · 44
3. 10.1086/50162010.1086/501620 ↗
4. Ethicon: a johnson & johnson company, Ethicon receiveds FDA clearance to market Vicryl* Plus, first ever antibacterial suture, Vol. 2006, 2002.
5. MaathuisP.G.M., BulstraS.K., in: RakhorstG., and PloegR. J. (Eds.), Biomaterials in modern medicine, World Scientific Publishing Company, New Jersey, 2008, pp. 97–112.
6. 10.1146/annurev.mi.41.100187.00225110.1146/annurev.mi.41.100187.002251 ↗
7. Elek S.D. · Br. J. Exp. Pathol. · 1957 · 38 · 573
8. Ratner B.D. · 2004
9. 10.1002/jbm.82021110210.1002/jbm.820211102 ↗
10. 10.1016/j.biomaterials.2003.08.00710.1016/j.biomaterials.2003.08.007 ↗
11. 10.1007/BF0236436910.1007/BF02364369 ↗
12. 10.1007/BF0236072510.1007/BF02360725 ↗
13. 10.1007/BF0235907810.1007/BF02359078 ↗
14. 10.1023/A:102296430941410.1023/A:1022964309414 ↗
15. 10.1016/S0266-3538(03)00178-710.1016/S0266-3538(03)00178-7 ↗
16. 10.1016/j.biomaterials.2008.01.01110.1016/j.biomaterials.2008.01.011 ↗
17. 10.1021/bp020042m10.1021/bp020042m ↗
18. 10.1002/jbm.b.3004110.1002/jbm.b.30041 ↗
19. 10.1016/S0168-3659(02)00041-X10.1016/S0168-3659(02)00041-X ↗
20. 10.1016/j.jconrel.2004.04.00910.1016/j.jconrel.2004.04.009 ↗
21. 10.1016/j.biomaterials.2005.11.03710.1016/j.biomaterials.2005.11.037 ↗
22. 10.1016/j.biomaterials.2005.10.02810.1016/j.biomaterials.2005.10.028 ↗
23. 10.1016/S0168-3659(03)00097-X10.1016/S0168-3659(03)00097-X ↗
24. 10.1016/S0168-3659(03)00342-010.1016/S0168-3659(03)00342-0 ↗
25. 10.1016/S0168-3659(03)00372-910.1016/S0168-3659(03)00372-9 ↗
26. 10.1002/polb.1019110.1002/polb.10191 ↗
27. 10.1016/S0032-3861(99)00068-310.1016/S0032-3861(99)00068-3 ↗
28. 10.1163/15685620175325251610.1163/156856201753252516 ↗
29. 10.1016/j.matlet.2008.03.03810.1016/j.matlet.2008.03.038 ↗
30. 10.1021/nl048615810.1021/nl0486158 ↗
31. 10.1016/j.synthmet.2005.07.05310.1016/j.synthmet.2005.07.053 ↗
32. 10.1002/app.2060210.1002/app.20602 ↗
33. 10.1016/j.addr.2007.04.02010.1016/j.addr.2007.04.020 ↗
34. 10.1016/j.polymer.2007.09.01710.1016/j.polymer.2007.09.017 ↗
35. 10.1002/app.2260210.1002/app.22602 ↗
36. 10.1016/j.polymer.2006.05.01210.1016/j.polymer.2006.05.012 ↗
37. 10.1016/0014-3057(72)90109-710.1016/0014-3057(72)90109-7 ↗
38. 10.1016/j.ijantimicag.2006.10.01510.1016/j.ijantimicag.2006.10.015 ↗
39. 10.1016/S0168-3659(98)00076-510.1016/S0168-3659(98)00076-5 ↗
40. 10.1016/j.polymer.2004.10.05410.1016/j.polymer.2004.10.054 ↗
41. 10.1016/j.polymdegradstab.2008.11.00110.1016/j.polymdegradstab.2008.11.001 ↗
42. 10.1007/s10570-007-9183-310.1007/s10570-007-9183-3 ↗
43. 10.1016/S0032-3861(02)00275-610.1016/S0032-3861(02)00275-6 ↗
44. 10.1016/0378-5173(85)90031-610.1016/0378-5173(85)90031-6 ↗
45. 10.1016/0168-3659(94)90003-510.1016/0168-3659(94)90003-5 ↗
46. 10.1016/S0168-3659(99)00083-810.1016/S0168-3659(99)00083-8 ↗
47. 10.1016/0168-3659(87)90034-410.1016/0168-3659(87)90034-4 ↗
48. 10.1002/mabi.20050014710.1002/mabi.200500147 ↗